Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001653477-25-000072
Filing Date
2025-05-05
Accepted
2025-05-05 17:59:44
Documents
6
Period of Report
2025-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1746482377.html 4  
1 FORM 4 wk-form4_1746482377.xml 4 3640
2 EX-24.1 ngvt_poax-xedgarxnextwri.htm EX-24.1 9472
3 ngvt_poax-xedgarxnextwri001.jpg GRAPHIC 251263
4 ngvt_poax-xedgarxnextwri002.jpg GRAPHIC 227003
5 ngvt_poax-xedgarxnextwri003.jpg GRAPHIC 45637
6 ngvt_poax-xedgarxnextwri004.jpg GRAPHIC 61509
  Complete submission text file 0001653477-25-000072.txt   821180
Mailing Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405
Business Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405 8437402300
Ingevity Corp (Issuer) CIK: 0001653477 (see all company filings)

EIN.: 474027764 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2800 Chemicals & Allied Products
(CF Office: 08 Industrial Applications and Services)

Mailing Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405
Business Address
Wright Benjamin G. (Reporting) CIK: 0001938475 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37586 | Film No.: 25914437